GTHR — GeneThera Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for GeneThera, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.758 | -4.04 | -0.518 | -0.774 | -1.01 |
| Depreciation | |||||
| Non-Cash Items | 0.14 | 2.93 | 0 | 0.015 | 0.51 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.519 | 0.645 | 0.513 | 0.749 | 0.488 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.098 | -0.463 | 0 | -0.005 | -0.009 |
| Capital Expenditures | -0.026 | 0 | — | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.026 | 0 | — | 0 | 0 |
| Financing Cash Flow Items | — | — | — | — | -0.011 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.292 | 0.3 | — | 0 | 0.009 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.168 | -0.163 | 0 | -0.005 | 0 |